RKDA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Arcadia Biosciences Inc (RKDA) is not a good buy for a beginner investor with a long-term strategy. The stock is in a bearish technical trend, has poor financial performance, and lacks positive news or catalysts. Additionally, there are no proprietary trading signals indicating a strong buy opportunity.
The stock is in a bearish trend with a negatively expanding MACD histogram (-0.0106), an oversold RSI (15.554), and bearish moving averages (SMA_200 > SMA_20 > SMA_5). The pre-market price is $1.05, down -0.94%, and the stock is trading near its support level (S1: 0.975).
NULL identified. No recent news, no positive trading trends, and no significant activity from hedge funds or insiders.
The company reported poor financial performance in Q4 2025, with significant YoY declines in revenue (-25.90%), net income (-67.13%), EPS (-67.45%), and gross margin (-33.39%). Additionally, the stock has a 40% chance of declining by -0.61% in the next day.
In Q4 2025, the company showed weak financials: revenue dropped to $901,000 (-25.90% YoY), net income dropped to -$1,336,000 (-67.13% YoY), EPS dropped to -$0.97 (-67.45% YoY), and gross margin dropped to 21.31% (-33.39% YoY).
No analyst rating or price target changes available.
